Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
1.160
+0.040 (3.57%)
Aug 27, 2026, 4:00 PM EDT - Market closed
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of $293.37 million as of August 27, 2026. Its market cap has increased by 2.79% in one year.
Market Cap
293.37M
Enterprise Value
244.84M
1-Year Change
2.79%
Ranking
Category
Stock Price
$1.16
ChartMarket Cap Chart
Since December 1, 1998, Lineage Cell Therapeutics's market cap has increased from $147.40M to $293.37M, an increase of 99.03%. That is a compound annual growth rate of 2.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 293.37M | -23.72% |
| Dec 31, 2025 | 384.60M | 305.70% |
| Dec 31, 2024 | 94.80M | -50.29% |
| Dec 29, 2023 | 190.70M | -4.12% |
| Dec 30, 2022 | 198.90M | -51.84% |
| Dec 31, 2021 | 413.00M | 56.44% |
| Dec 31, 2020 | 264.00M | 98.05% |
| Dec 31, 2019 | 133.30M | 15.01% |
| Dec 31, 2018 | 115.90M | -57.51% |
| Dec 29, 2017 | 272.80M | -26.90% |
| Dec 30, 2016 | 373.20M | -4.09% |
| Dec 31, 2015 | 389.10M | 25.52% |
| Dec 31, 2014 | 310.00M | 28.15% |
| Dec 31, 2013 | 241.90M | 51.38% |
| Dec 31, 2012 | 159.80M | -45.26% |
| Dec 30, 2011 | 291.90M | -26.38% |
| Dec 31, 2010 | 396.50M | 181.41% |
| Dec 31, 2009 | 140.90M | 234.68% |
| Dec 31, 2008 | 42.10M | 347.87% |
| Dec 31, 2007 | 9.40M | 54.10% |
| Dec 29, 2006 | 6.10M | 10.91% |
| Dec 30, 2005 | 5.50M | -79.55% |
| Dec 31, 2004 | 26.90M | 43.09% |
| Dec 31, 2003 | 18.80M | -10.05% |
| Dec 31, 2002 | 20.90M | -60.79% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 294.51M |
| AC Immune | 290.33M |
| Turn Therapeutics | 289.84M |
| Whitehawk Therapeutics | 289.61M |
| Sionna Therapeutics | 282.58M |
| Eledon Pharmaceuticals | 282.25M |
| Neumora Therapeutics | 281.84M |
| Camp4 Therapeutics | 279.25M |